Fasenra
Benralizumab · AstraZeneca Pharmaceuticals LP
PRESCRIPTION ONLY (USA)Fasenra ingredients
| Active ingredient | Strength |
|---|---|
| Benralizumab | 30 mg/mL, 10 mg/.5mL |
What Fasenra is used for
Fasenra is a specialist medicine (interleukin-5 receptor alpha-directed cytolytic antibody). Its approved uses are listed on the official FDA label below.
Key facts
- Brand
- Fasenra
- Generic name
- Benralizumab
- Made by
- AstraZeneca Pharmaceuticals LP
- Forms
- Injection, Solution
- Given
- Subcutaneous
- Drug class
- Interleukin-5 Receptor alpha-directed Cytolytic Antibody
- FDA approval
- Biologic licence (BLA) BLA761070
- On the US market since
- 2017
Official information
- Fasenra prescribing information (FDA label) on DailyMed
- MedlinePlus drug information (search for Benralizumab)
Specialist medicine: started and supervised by a specialist doctor or hospital. This page is a plain-language summary of public official information, not medical advice; follow your doctor and the official product information.
Common questions
What is Fasenra?
Fasenra (Benralizumab) is a specialist medicine made by AstraZeneca Pharmaceuticals LP, approved by the US FDA.
What are the ingredients of Fasenra?
Fasenra contains Benralizumab (30 mg/mL, 10 mg/.5mL).
From the FDA National Drug Code directory (open.fda.gov, public domain). Page made 5 November 2026 by Satya Babu.
← All specialty medicines, USA